Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Forbes

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysisJohn F Forbes, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision makingAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Lancet (London, England)|December 17, 2019
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment receivedAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
The Lancet. Oncology|December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trialIvana Sestak, Shalini Singh, Jack Cuzick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to VMarco Colleoni, Zhuoxin Sun, Karen N Price, et al.
Scientific Reports|September 28, 2016
DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patientsAndrea Mathe, Michelle Wong-Brown, Warwick J Locke, et al.
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Molecular Oncology|May 27, 2015
Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancerJay Pundavela, Severine Roselli, Sam Faulkner, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysisJohn F Forbes, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision makingAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Lancet (London, England)|December 17, 2019
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategyAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
Journal of Vascular Surgery|May 4, 2010
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment receivedAndrew W Bradbury, Donald J Adam, Jocelyn Bell, et al.
The Lancet. Oncology|December 3, 2014
Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trialIvana Sestak, Shalini Singh, Jack Cuzick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to VMarco Colleoni, Zhuoxin Sun, Karen N Price, et al.
Scientific Reports|September 28, 2016
DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patientsAndrea Mathe, Michelle Wong-Brown, Warwick J Locke, et al.
The Lancet. Oncology|December 15, 2010
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trialJack Cuzick, Ivana Sestak, Sarah E Pinder, et al.
Molecular Oncology|May 27, 2015
Nerve fibers infiltrate the tumor microenvironment and are associated with nerve growth factor production and lymph node invasion in breast cancerJay Pundavela, Severine Roselli, Sam Faulkner, et al.
Pageof 9